Deliver a professional gastro-oesophageal reflux disease (GORD) service through Scripter's structured consultation pathway. Supply: Omeprazole 10 mg and 20 mg.
Omeprazole is a proton pump inhibitor (PPI), one of the most effective acid-suppressing medicines available. By switching off the stomach's acid pumps at their source, they let an inflamed oesophagus heal and keep heartburn and regurgitation controlled with a single daily dose. The consultation selects the strength that fits the presentation and the governing PGD's criteria.
Gastro-oesophageal reflux disease is the backflow of stomach acid into the oesophagus, felt as heartburn, regurgitation and an acid taste, typically worse after meals, at night or on bending. Frequent reflux erodes the oesophageal lining and quality of life in equal measure. Just as important is what GORD is not: swallowing difficulty, weight loss, bleeding or persistent vomiting are alarm features of something else, which is why this pathway screens before it supplies.
Patients book online, complete the pre-consultation questionnaire, and the guided pathway walks the practitioner through the gastro-oesophageal reflux disease (GORD) consultation with the screening and counselling steps built in. The supply decision, the record and any GP notification are produced in the same flow, documented against the exact protocol version in force.
Who can deliver this service, and who it can be delivered to. The governing PGD document defines the definitive inclusion, exclusion and supply criteria; the Scripter consultation pathway enforces them, and every consultation is documented against the protocol version it ran under.
Related protocols in the same category, all delivered through the same platform.
See the consultation pathway, the sign-off tracking and the record it produces in a free 30-minute demo.